Protease inhibitor combination antiretroviral therapy

This page covers all Protease inhibitor combination antiretroviral therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV protease, HIV reverse transcriptase.

Targets

HIV protease, HIV reverse transcriptase

Marketed (1)

• Ritonavir boosted Atazanavir + 2 NRTIs · Fundacion SEIMC-GESIDA · Infectious Disease
  Atazanavir inhibits HIV protease to prevent viral replication, while ritonavir boosts its blood levels, and the two NRTIs block reverse transcriptase to further suppress HIV.

Patent intelligence

• protease inhibitor combination antiretroviral therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates